Episode

Author Interview: Doctor Chung-Mao Kao, May 2026

Podcast
The IMID Forum
Published
Jun 23, 2026
Duration seconds
829
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/author-interview-doctor-chung
Audio
https://feeds.soundcloud.com/stream/2344719587-imidforum-author-interview-doctor-chung.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-doctor-chung-mao-kao-may-2026
Markdown
/podcast/the-imid-forum-981476/author-interview-doctor-chung-mao-kao-may-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-doctor-chung-mao-kao-may-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/author-interview-doctor-chung-mao-kao-may-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication ‘Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: A 5-year population-based cohort study’.